Iron Absorption From Plant Heme Iron
NCT07143890 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2026-02-12
Summary
Heme, an iron protoporphyin IX complex, consists of a ferrous ion captured in a porphyrin ring acting as a tetradentate ligand. The unique features of heme iron -its unusually high absorption in foods and its resistance to luminal inhibitors of iron absorption- make it a potentially interesting iron fortificant. This study aims to compare fractional iron absorption from two plant-derived heme iron compounds-iron chlorophyllin and soy hemoglobin-with ferrous sulfate (negative control) and porcine hemoglobin (positive control) in iron-deficient women. All four compounds will be intrinsically labeled with stable iron isotopes. Fractional absorption will be assessed 14 days after test meal administration via erythrocyte iron incorporation.
Absorption will be tested in two matrices: water and maize porridge (an inhibitory matrix). Each participant will consume all test conditions in a randomized order, allowing for within-subject comparisons.
Conditions
- Iron Deficiency (ID)
- Iron Absorption
Interventions
- OTHER
-
Iron chlorophyllin + no-matrix
Water with labelled Fe chlorophyllin (54Fe)
- OTHER
-
SoyHb + no-matrix
Water with labelled soy hemoglobin (58Fe)
- OTHER
-
FeSO4 + no-matrix
Water with labelled ferrous sulfate (58Fe)
- OTHER
-
Hb + no-matrix
Water with labelled porcine hemoglobin (57Fe)
- OTHER
-
Iron chlorophyllin + meal-matrix
Maize porridge with labelled Fe chlorophyllin (54Fe)
- OTHER
-
SoyHb + meal-matrix
Maize porridge with labelled soy hemoglobin (58Fe)
- OTHER
-
FeSO4 + meal-matrix
Maize porridge with labelled ferrous sulfate (57Fe)
- OTHER
-
Hb + meal-matrix
Maize porridge with labelled porcine hemoglobin (57Fe)
Sponsors & Collaborators
-
ETH Zurich
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-22
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- Switzerland
Study Locations
More Related Trials
-
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
NCT04778072 ·Status: UNKNOWN ·Phase: NA
-
Iron Absorption From Tef-injera in Women of Reproductive Age
NCT01687062 ·Status: COMPLETED ·Phase: NA
-
Different Iron Supplements for Prevention of Anemia in Pregnancy
NCT02487719 ·Status: UNKNOWN ·Phase: PHASE4
-
Iron Long-Term Labelling Study Switzerland
NCT02979132 ·Status: UNKNOWN ·Phase: NA
-
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement
NCT03990181 ·Status: COMPLETED ·Phase: NA
-
Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal Women
NCT01374776 ·Status: COMPLETED ·Phase: PHASE4
-
Hypoferritinemia Without Anemia Among Reproductive Age Females
NCT06437080 ·Status: COMPLETED ·Phase: NA
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Frequency and Impact of Iron Deficiency in Pain Clinic Patients
NCT06665516 ·Status: COMPLETED
-
Determination of Iron Absorption and Losses in People Living at High Altitude to Investigate the Requirements in This Population Group Using a Newly Developed Technique
NCT07142590 ·Status: RECRUITING ·Phase: NA
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
NCT07199244 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Effect of Polyphenols on Iron Absorption From Finger Millet
NCT04194567 ·Status: COMPLETED ·Phase: NA
-
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
NCT00000588 ·Status: COMPLETED ·Phase: PHASE2
-
Measuring Menstrual Iron Loss Using the Iron Isotope Dilution Technique
NCT05788172 ·Status: COMPLETED
-
Effect of Health Information Package Program on Knowledge and Compliance Among Pregnant Women With Anemia
NCT04661865 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia
NCT02731534 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
NCT00689793 ·Status: COMPLETED ·Phase: PHASE4
-
ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)
NCT05697211 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study
NCT00386126 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Absorption of Heme and Non-Heme Iron in Pregnant and Non-pregnant Women and Mechanisms of Fetal Iron Transfer
NCT01019096 ·Status: COMPLETED
-
A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron
NCT01865175 ·Status: WITHDRAWN ·Phase: PHASE4
-
Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX
NCT03231865 ·Status: COMPLETED
-
Anemia and Inflammation
NCT03618914 ·Status: COMPLETED